Moreover, BRCA1/2 PV carriers were more likely to be in FIGO stage III-IV, andthe pathological type of BRCA1/2 PVs carriers wasmore likely to be high-grade serous carcinoma. This evidence concerns the gene BRCA1 and serous adenocarcinoma.